CNSX:MMENMedmen Enterprises Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Medmen Enterprises Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.32 +0.01 (+3.23 %) (As of 06/3/2020 02:11 PM ET) Add Compare Share Today's Range$0.31Now: $0.32▼$0.3350-Day Range N/A52-Week Range N/AVolume333,864 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsInsider TradesHeadlines MedMen Enterprises Inc., together with its subsidiaries, operates as a cannabis company in the United States. The company cultivates, produces, and distributes, and retails recreational and medicinal cannabis. As of November 1, 2018, it had licenses for 69 retail stores; and 17 cultivation and production facilities across 12 states. The company is headquartered in Culver City, California.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Medmen Enterprises. Previous Next 3.2 Community Rank Outperform VotesMedmen Enterprises has received 33 “outperform” votes. (Add your “outperform” vote.)Underperform VotesMedmen Enterprises has received 19 “underperform” votes. (Add your “underperform” vote.)Community SentimentMedmen Enterprises has received 63.46% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Medmen Enterprises and other stocks. Vote “Outperform” if you believe MMEN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MMEN will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldMedmen Enterprises does not currently pay a dividend.Dividend GrowthMedmen Enterprises does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Medmen Enterprises insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $341,179.00 in company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 3.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.64 out of 5 stars Industry, Sector and Symbol Stock Exchange CNSX Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolCNSX:MMEN Previous Symbol CUSIPN/A CIKN/A Webwww.medmen.com Phone424-341-4969Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable TSXV:MMEN Rates by TradingView Receive MMEN News and Ratings via Email Sign-up to receive the latest news and ratings for MMEN and its competitors with MarketBeat's FREE daily newsletter. Medmen Enterprises (CNSX:MMEN) Frequently Asked Questions Has Medmen Enterprises been receiving favorable news coverage? Media coverage about MMEN stock has been trending somewhat positive this week, InfoTrie reports. The research firm rates the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Medmen Enterprises earned a news sentiment score of 1.7 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 6.0 out of 10, meaning that recent press coverage is somewhat likely to have an impact on the company's share price in the near future. View the latest news aboutMedmen Enterprises. Who are some of Medmen Enterprises' key competitors? Some companies that are related to Medmen Enterprises include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannabis Science (CBIS), Cannara Biotech (LOVE), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF) and Cipher Pharmaceuticals (CPHRF). View all competitors. What other stocks do shareholders of Medmen Enterprises own? Based on aggregate information from My MarketBeat watchlists, some companies that other Medmen Enterprises investors own include Aurora Cannabis (ACB), Aurora Cannabis (ACB), Medmen Enterprises (MMNFF), Green Organic Dutchman (TGOD), OrganiGram (OGI), Canopy Growth (CGC), CannTrust (CTST), Canopy Growth (WEED), Cronos Group (CRON) and HEXO (HEXO). Who are Medmen Enterprises' key executives? Medmen Enterprises' management team includes the following people: Mr. Adam Bierman, Co-Founder, CEO & Director (Age 38)Mr. Andrew Modlin, Co-Founder, Pres & Director (Age 32)Mr. Michael W. Kramer, Chief Financial Officer (Age 55)Mr. James Miller, VP of Accounting (Age 59)Mr. Ryan Lissack, Chief Technology Officer What is Medmen Enterprises' stock symbol? Medmen Enterprises trades on the CNSX under the ticker symbol "MMEN." How do I buy shares of Medmen Enterprises? Shares of MMEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Medmen Enterprises' stock price today? One share of MMEN stock can currently be purchased for approximately $0.32. What is Medmen Enterprises' official website? The official website for Medmen Enterprises is www.medmen.com. How can I contact Medmen Enterprises? The company can be reached via phone at 424-341-4969. This page was last updated on 6/3/2020 by MarketBeat.com Staff
